NAPSRX CNPR EXAM |160 QUESTIONS WITH 100% CORRECT ANSWERS (REVISED
18TH EDITION) |VERIFIED | UPDATED
1. whatdoes a STATorder mean?
c c c c c
..ANSWER>>a drug needed immediately and given only once c c c c c c c
2. what information does the overdosage
c c c c
section of the labeling provide?
c c c c c
..ANSWER>>signs, symptoms and treatment of acute overdoses c c c c c c
3. types of drug-drug interac- duplication, opposition (antagonism) and alteration (p.51)
c c c c c c c c c
tions:
4. tolerance vs resistance c c ..ANSWER>>tolerance is the diminished response to a drug; resistance is the cells c c c c c c c c c c c
ability to resist the ettects of the drug on them.
c c c c c c c c c
5. abbreviated new drug ap- plication c c c c
..ANSWER>>the process by which applicants must scientifically demonstrate to the c c c c c c c c c
c (ANDA) c FDA that their generic product is bioequivalent to or performs in the same way as the
c c c c c c c c c c c c c c c
c innovator drug, no duplicate testing (p. 75)
c c c c c c
6. theHatch-Waxman Act of 1984
c c c c
..ANSWER>>-A.K.A. Drug Price Competition and Patent Restoration Act c c c c c c c
-made it easier to bring generic drugs to the market by requiring the FDA to only look at
c c c c c c c c c c c c c c c c c
c bioavailability studies in order to approve an ANDA.
c c c c c c c
-gave protection to the research based manufacturers by providing a 30-month automatic cooling
c c c c c c c c c c c c
c ott period once an ANDA is challenged for patent infringement (p. 75)
c c c c c c c c c c c
7. fourbasic transport mech- anisms
c c c c
..ANSWER>>passive dittusion, facilitated dittusion, active transport, and pinocy- tosis c c c c c c c c
c (p. 95)
c
c c
, 8. potency vs efficacy
c c ..ANSWER>>potency: amount of drug necessary to produce desired ettect
c c c c c c c c
eflcacy: magnitude of maximal response that can be received from a drug
c c c c c c c c c c c
*eflcacy is almost always more important that potency* (p. 106)
c c c c c c c c c
c c
18TH EDITION) |VERIFIED | UPDATED
1. whatdoes a STATorder mean?
c c c c c
..ANSWER>>a drug needed immediately and given only once c c c c c c c
2. what information does the overdosage
c c c c
section of the labeling provide?
c c c c c
..ANSWER>>signs, symptoms and treatment of acute overdoses c c c c c c
3. types of drug-drug interac- duplication, opposition (antagonism) and alteration (p.51)
c c c c c c c c c
tions:
4. tolerance vs resistance c c ..ANSWER>>tolerance is the diminished response to a drug; resistance is the cells c c c c c c c c c c c
ability to resist the ettects of the drug on them.
c c c c c c c c c
5. abbreviated new drug ap- plication c c c c
..ANSWER>>the process by which applicants must scientifically demonstrate to the c c c c c c c c c
c (ANDA) c FDA that their generic product is bioequivalent to or performs in the same way as the
c c c c c c c c c c c c c c c
c innovator drug, no duplicate testing (p. 75)
c c c c c c
6. theHatch-Waxman Act of 1984
c c c c
..ANSWER>>-A.K.A. Drug Price Competition and Patent Restoration Act c c c c c c c
-made it easier to bring generic drugs to the market by requiring the FDA to only look at
c c c c c c c c c c c c c c c c c
c bioavailability studies in order to approve an ANDA.
c c c c c c c
-gave protection to the research based manufacturers by providing a 30-month automatic cooling
c c c c c c c c c c c c
c ott period once an ANDA is challenged for patent infringement (p. 75)
c c c c c c c c c c c
7. fourbasic transport mech- anisms
c c c c
..ANSWER>>passive dittusion, facilitated dittusion, active transport, and pinocy- tosis c c c c c c c c
c (p. 95)
c
c c
, 8. potency vs efficacy
c c ..ANSWER>>potency: amount of drug necessary to produce desired ettect
c c c c c c c c
eflcacy: magnitude of maximal response that can be received from a drug
c c c c c c c c c c c
*eflcacy is almost always more important that potency* (p. 106)
c c c c c c c c c
c c
